Kidney Biopsy Profiling: Revealing Drug Mechanisms & Responsive Patient Subgroups in Kidney Disease Trials
- Profiling patient kidney tissue before and during clinical trials to understand molecular changes and identify early signals of therapeutic response
- Comparing trial biopsy data with longitudinal cohort datasets to determine where drugs succeed or fail mechanistically
- Advancing precision medicine by linking molecular tissue changes with clinical outcomes and guiding future biomarker-driven trial design